COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 604: Articles 6031-6040  | Next

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
Andeweg, S. P., de Gier, B., Vennema, H., van Walle, I., van Maarseveen, N., Kusters, N. E., de Melker, H. E., Hahne, S. J. M., van den Hof, S., Eggink, D., Knol, M. J.
10.1101/2022.09.21.22280189 — Posted: 2022-09-23
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Mhlekude, B., Postmus, D., Weiner, J., Stenzel, S., Zapatero-Belinchon, F. J., Olmer, R., Jansen, J., Richter, A., Heinze, J., Heinemann, N., Muhlemann, B., Schroeder, S., Jones, T. C., Muller, M. A., Drosten, C., Pich, A., Thiel, V., Martin, U., Niemeyer, D., Gerold, G., Beule, D., Goffinet, C.
10.1101/2022.09.22.508962 — Posted: 2022-09-23
Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection
Zhou, T., Gilliam, N. J., Li, S., Spaudau, S., Osborn, R., Anderson, C. S., Mariani, T. J., Thakar, J., Dewhurst, S., Mathews, D. H., Huang, L., Sun, Y.
10.1101/2022.09.22.509123 — Posted: 2022-09-23
Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization
Morris, C. P., Eldesouki, R., Sachithanandham, J., Fall, A., Norton, J., Abdullah, O., Gallagher, N., Li, M., Pekosz, A., Klein, E., Mostafa, H.
10.1101/2022.09.20.22280154 — Posted: 2022-09-23
A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses
Ryan, F. J., Norton, T. S., McCafferty, C., Blake, S. J., Stevens, N. E., James, J., Eden, G. L., Tee, Y. C., Benson, S. C., Masavuli, M. G., Yeow, A. E., Abayasingam, A., Agapiou, D., Stevens, H., Zecha, J., Messina, N. L., Curtis, N., gnjatovic, V., Monagle, P., Tran, H., McFadyen, J. D., Bull, R., Grubor-Bauk, B., Lynn, M. A., Botten, R., Barry, S. E., Lynn, D.
10.1101/2022.09.22.22280180 — Posted: 2022-09-23
Separating Signal from Noise in Wastewater Data: An Algorithm to Identify Community-Level COVID-19 Surges
Keshaviah, A., Huff, I., Hu, X. C., Guidry, V., Christensen, A., Berkowitz, S., Reckling, S., McLellan, S., Roguet, A., Mussa, I.
10.1101/2022.09.19.22280095 — Posted: 2022-09-23
Adherence to and experiences of K-12 students in modified and standard home quarantine during the SARS-CoV-2 pandemic in Missouri
Worrell, M. C., Malone, S., Dawson, P., Fritz, S. A., Thomas, E., Peeler, B., Rains, C., Tinker, S. C., Neatherlin, J. C., Barrios, L., Mooney, J., Towns, K., Newland, J., Salzer, J. S.
10.1101/2022.09.19.22280101 — Posted: 2022-09-23
Simplified Within Host and Dose-response Models of SARS-CoV-2
Xu, J., Carruthers, J., Finnie, T. J. R., Hall, I.
10.1101/2022.09.20.22279832 — Posted: 2022-09-22
Triple COVID-19 vaccination induces humoral and cellular immunity to SARS-CoV-2 with cross-recognition of the Omicron variant and IgA secretion
Ruhl, L., Kuehne, J. F., Beushausen, K., Keil, J., Christoph, S., Sauer, J., Falk, C. S.
10.1101/2022.09.22.508999 — Posted: 2022-09-22
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
Alsoussi, W. B., Malladi, S. K., Zhou, J. Q., Liu, Z., Ying, B., Kim, W., Schmitz, A. J., Lei, T., Horvath, S. C., Sturtz, A. J., McIntire, K. M., Evavold, B., Han, F., Scheaffer, S. M., Fox, I. F., Parra-Rodriguez, L., Nachbagauer, R., Nestorova, B., Chalkias, S., Farnsworth, C. W., Klebert, M. K., Pusic, I., Strnad, B. S., Middleton, W. D., Teefey, S. A., Whelan, S. P. J., Diamond, M. S., Paris, R., O'Halloran, J. A., Presti, R. M., Turner, J. S., Ellebedy, A. H.
10.1101/2022.09.22.509040 — Posted: 2022-09-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).